Maria Carvajal Perea: Prothrombin Complex Concentrate vs Plasma – Optimizing Hemostasis After Cardiac Surgery
Maria Carvajal Perea, Basic Life Support for Healthcare Providers (BLS) at American Heart Association, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Colombian Journal of Anesthesiology, adding:
“I am thrilled to share the publication of my first scientific article as a co-author in the Colombian Journal of Anesthesiology!
‘Prothrombin complex concentrate versus plasma for coagulopathic bleeding after cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis.’
Managing coagulopathic bleeding after cardiac surgery requires rapid, evidence-based decisions. In this systematic review and meta-analysis, our team prioritized clinically relevant hemostatic outcomes rather than relying solely on surrogate laboratory markers.
Main Findings from Meta-Analysis:
- Hemostatic Control: Prothrombin complex concentrate (PCC) significantly reduced clinically relevant hemostatic failure compared to plasma strategies (RR 0.55; 95% CI 0.42–0.70).
- Renal Protection: PCC was associated with a lower risk of acute kidney injury (RR 0.57; 95% CI 0.35–0.91).
- Safety Profile: While results are promising, larger studies are still needed to more precisely define safety conclusions regarding thromboembolic events and mortality.
Being part of this inter-institutional project has been an incredibly valuable learning experience, further strengthening my commitment to research, academic medicine, and anesthesiology.
I’m very grateful to my co-authors and the entire research team for their invaluable scholarly guidance, rigorous feedback, and collaborative effort throughout this study.
Proud to see our work published.”
Title: Prothrombin complex concentrate versus plasma for coagulopathic bleeding after cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis
Authors: Paula A. Henríquez Miranda, Betty Gabriel Valencia Angarita, María Carvajal Perea, Mayra Alejandra Parada Navarro, Valentina Moreno Goyeneche, María Camila Madariaga Estupiñán

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 21, 2026, 13:06Christine Faressa: Precision PRP and Platelet Biology in Musculoskeletal Care
-
Nov 21, 2026, 13:04Eyad Jamileh: Atrial Fibrillation – Bridging the Global Gaps in Diagnosis and Stroke Prevention
-
Nov 21, 2026, 12:49Thibault Veyron: Optimizing Bivalirudin Treatment in HIT
-
Nov 21, 2026, 12:44Paulus Kirchhof: Left Atrial Appendage Occlusion vs DOACs
-
Nov 21, 2026, 12:19Jiyeon Kim: Human Platelet Lysate – Advancing Cell Therapy and Space Research
-
Nov 21, 2026, 12:13Chaza Alaji: DVT in Early Pregnancy – Why Anticoagulation Decisions Matter
-
Nov 21, 2026, 12:06Salih Ehsan: Why Iron Therapy May Not Work
-
Nov 21, 2026, 11:59Edward Lee Carter: DOACs vs Warfarin for LV Thrombus – Are We Getting Closer to an Answer?
-
Nov 21, 2026, 11:50Abdul Mannan: When G6PD Testing Misleads During Acute Hemolysis